Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Smart !! That’s what I’m talking about!
No one wants to give this AMAZING $BLEG a multiple!!
My price targets are WITH THE MOST MINIMAL multiple!
See ya in SILVER LAND for STARTERS!
$BLEG
$BLEG system check..
ROCKET ENGINES firing up!!
Let’s put new 52 week high in this week!
CHART is set for a MONSTER RUN!!
$BLEG
Chart is
AMAZING!!
$BLEG
Higher highs
Higher lows
STRONG CHANNEL
Great $BLEG summary!!
UFC sharky..... “LETS GET IT ON!”
$BLEG superstar!!
Super tight float, we shareholders are STRONG with our STRONG CEO DAVE!!
L E T ‘S
G E T
I T
O N ! 🚀🚀🚀
Priceless Prophet !! $BLEG doing everything they can to do it RIGHT!
QUALITY !!
$BLEG
Imagine pre market news if that along with a MONSTER KAVA CONTRACT!!
Recurring revenues !!
$BLEG
Well stated a Biochem $BLEG!!
Hi Bambam,
Thanks so much and Kindly post the article for reference please so we can LINK IT to DD page!
$BLEG
TIK tok TRADING FLOOR opening for $BLEG
Very nice comments SWIM, and sums it up so nicely!
TEAMWORK makes the DREAM WORK!!
$BLEG
Respectfully,
Maverick
$BLEG
Biochem!! That’s HUGE and I smell COPPER THIS WEEK!!
Woohoo!!
$BLEG
Respectfully,
Maverick
$BLEG
Fantastic post Varok! Very nice summary and to the point! It’s nice to have fresh eyes here and contribute to $BLEG team!
I noticed on your post you didn’t include our acquisition of Sycamore.
I BELIEVE many positive developments coming for example, DEA reschedule marijuana from schedule 1 to schedule 3 drug.
Also Florida Proposition 3 which the Florida Supreme Court approved for voters to vote on here in November and our HQ is in Florida etc!
I also feel our extraction company MARiJ PHARMA will be HUGE especially when we see the revenues it will be producing in QUARTER 2 2024!
Thanks for your contributions and I feel based on above we can support a .05-.07 share valuation and this is without our CEO buying back any PREFERREDS which would CATAPULT this much higher in my opinion!
All the Best!
March 12,2024 !
Keep up the Excellent work and I feel the share price should be adjusted upwards with Sycamore and the inventory as well!
Respectfully,
Maverick
$BLEG
Sycamorebp.com
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy"
MELBOURNE, Fla., March 12, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.
Renowned for its meticulous development of wellness solutions, ranging from gummies to compression sleeves and pain-relieving topical creams, Sycamore BioPharma has earned acclaim as a prolific product developer. The acquisition brings forth over $500,000 in high-quality, ready-to-sell inventory and aligns seamlessly with Branded Legacy's dedication to quality, authenticity, and a commitment to natural ingredients.
David Oswald, CEO at Branded Legacy, Inc., expresses enthusiasm about the acquisition, stating, "Branded Legacy is thrilled to embrace Sycamore BioPharma into our family of companies. This tactical move not only compliments our existing portfolio, but also brings us several steps closer to our goal of achieving FDA approval for several of our pharmaceutical products.."
The acquisition not only opens new markets for Sycamore BioPharma but also provides access to Branded Legacy's extensive network, enhancing the company's ability to connect with consumers, build brand loyalty, and drive sales growth. It was also a crucial step in securing and maintaining a slew of large white label manufacturing and extraction contracts.
Tyler Stone, President of Sycamore Biopharma, Inc., is also enthusiastic about the acquisition stating, "Branded Legacy brings significant strengths in areas where Sycamore BioPharma was seeing significant challenges. Their network and consumer outreach will undoubtedly drive sales growth of our innovative products and we are proud to be a part of the Branded Legacy network of companies."
The collaboration between Branded Legacy and Sycamore BioPharma is poised to unlock synergies across various business facets. Leveraging Branded Legacy's web properties, brand management, and marketing expertise, the integration aims to maximize the reach and impact of Sycamore BioPharma's groundbreaking wellness solutions. Furthermore, the addition of Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy's roster will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials.
Dr. Mark T. Hamann, the newly appointed Director of Clinical Trials at Branded Legacy, brings a wealth of expertise as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina College of Pharmacy. Holding Adjunct appointments with The University of Maryland's Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine, Dr. Hamann's distinguished career commenced in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota.
Throughout his career, Dr. Hamann has authored over 250 scientific papers, reviews, and book chapters, while mentoring over 100 graduate students, postdoctoral fellows, and visiting scholars. Dr. Hamann's graduate studies led to the discovery of the anticancer agent, kahalalide F, which advanced to clinical trials in collaboration with biotech company PharmaMar. Currently serving as an Associate Editor for Biochimica et Biophysica Acta, General Subjects, Dr. Hamann's research group is actively engaged in the isolation, structure determination, and synthesis optimization of natural products and toxins. Their focus on plant and invertebrate microbiomes aligns with Branded Legacy's commitment to sustainable pharmaceutical development.
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
EXCELLENT POST VAROK. TEAM BLEG- I hope everyone had a great weekend. Rest up we have a very busy week ahead of us. BLEG IS SUPER GOLDEN!
Kava
$200Billion USA industry by 2026
Just reread your post. Impressive! Besides so many positives you discuss, I noticed that your price range target has edged upwards. I won’t complain. I’m sure someone’s gonna pin your post . Once again, great insight of the Company’s potential as well as stating what has been achieved/accomplished so far.
👀***From Barchart.....
https://www.barchart.com/stocks/quotes/BLEG/overview
👀***Insider Trading Screener-" Add symbol"......
SecForm4.Com
https://www.secform4.com › insider-trading-screener
Wow!! Much appreciated post!
And I thought you had a long weekend LOL! 😂 🤣
$BLEG 🚀
Don’t forget guys, name change is near. It’s already showing in some brokers: Royal Enterprise.
BLEG organic growth revenue-wise without being overburdened with debt. A small OS with zero notes on the balance sheets. A great CEO who understands shareholder interests. $0.01 is coming…
& yes, I’m excited for what’s ahead of us. Those with patience should benefit big time.
Great recap, & thanks for sharing your well thought out thoughts.
Love it, well said,
🍀NEW MANAGEMENT NEW VENTURE!🍀......The Best is Yet To Come!.....
Thanks for keeping it real.
The Sunday Newsletter - BLEG
Let's recap last week:
The shares are tightly held in strong hands and the trading range and who is in control is absolutely shown that we traders are in control. You can see the resiliency of a strong share structure and what effect it has on the price movement. The weekly chart is absolutely a beautiful sight to see. in the mid .0005We had two days of a downdraft but was short lived and only presented shareholders with opportunities to average in and get lower costs simply to anxiety from shareholders that have lost control of their emotions and trailed the negative sentiment in selling. Only to be amazed how we bounced back that was Wednesday on the misunderstanding on the OTC misclassification which was remedied the next day. I noticed looking at the chart for Friday and noticed another downdraft and this one appears to be somewhat more significant and wanted to confront this with real interest and found by cruising through ihub's posts that somebody wrote that Redditt opened a trading thread. Now this made me feel somewhat relieved since the young Turks over at Redditt do not play well with other children and happen to play outside of their sandbox and throwing sand in everyone's gears. That group over there are notorious for disrupting normal events and believe they caused the dip. As you can see, after the downdraft we went back to normal order and just showed how resilient the trading sessions for the week has been from the previous day's but still within the support of .0055 where we ended Friday with a perfect setup for this week.
The more I look and analysis the company the more I really like it. The main positive is the company currently does not have outstanding promissory, convertible notes, convertible debentures. This is the attractiveness of the company. Reason why I say this is that it is extremely difficult for a Penny Stock to conduct extensive program of Bio-tech research not to have these debt instruments. They have evolved into a very viable company and has put us on a path for solid growth going forward. The R/D is behind us and now we move into a new phase and execute their hard work into an FDA approved business model. The clinical trials.
This phase is the most important and allows the company to maximize their R/D efforts into a legitimate and save environmentally process and very much needed to move forward. It is this stage that will determine the viability of the company's business model. The are a few stages of Clinical trials. This week we have been getting information via twitter that the manufacturing plant is getting their inspection and of course to move forward this has to get the seal of approval before the next step. Let's hope this approval come through without hiccups.
The clinical trials on all companies can take 2-7 years and the latter is usually based on pharmaceutical companies with extensive medical saving medicines like cancer and such. We are not in this category, but nevertheless we do have a product that is eventually going to be used by humans and the procedure in clinical trials is as detailed and exact, but I believe, that a fast-track method and the process won't take as long giving the nature of the product itself.
The corporate structure is in itself a really smart endeavor on the company's part.
Branded Legacy, Inc. is a holding company that specializes in alkaloid extraction, refinement, and synthesis, as well as formulation and co-packing. Its primary focus is the commercial development of alkaloid-infused products such as vapes, tinctures, topicals, and gummies. We have a secondary focus on brand development, marketing, and overall sustainability. This on the surface details what the company is all about, but the underpinning or its corporate makeup is what is very important and just plain smart in the building the entire thesis.
See the company is built on the Vertical Organizational Structure: This departmental structure is an absolute way of allowing all steps of the company to be run by inhouse top tier management and its departments to the raw materials to the end product and finally into the sales end and onto the public domain. No disruptions from outsourcing or any delays that encompass many companies that rely beyond their control. Not here. The company is fully integrated. Good for the company and great for us shareholders ROI.
The acquisition of the various partnership/collaborations is what makes this a superb company. They kept on board the same teams of top management that was in the acquisition allowing for a unified transfer without embarking on a new team to familiarize with the organizational aspect that narrowed the time constraints for up and running into the new entity. Smart indeed.
List any subsidiaries, parent company, or affiliated companies:
Total Refinement Solutions, LLC (DBA Royal Biotek) is a wholly owned subsidiary with a proven track record of quality and efficiency. Our operations focus on the extraction, refinement, synthesis, and formulation necessary to support our co-packing endeavors. We have patentable intellectual property including product formulations and standard operating procedures. We perform extraction/refinement services both for our in house brands as well as on contract for our external partners. Our assets include a state of the art lab facility capable of processing several hundred kilograms of raw material per day.
The Alcannabist, LLC is a wholly owned subsidiary specializing in proprietary formulations encompassing a range of wellness products containing CBD, Mitragynine, Kavatones, and functional mushrooms. Its mission is to provide effective, natural solutions for various health concerns while also serving as an open market hub for marketing and distributing related products. With several product lines specifically formulated to treat migraine headaches, anxiety, pain, sleeplessness, and others, we offer vapes, gummies, tinctures, and topicals.
Rocket Web Development and Design, LLC (RWDD) is another wholly owned subsidiary, and is a leading web development company that has been developing and supporting various businesses in multiple industries for the past 7 years. Our consistent growth over this period has been a testament to our commitment to quality, innovation, and client satisfaction.
RWDD is revolutionizing our digital capabilities with its bespoke web development and comprehensive digital marketing solutions. This strategic integration not only enhances our subsidiaries' online presence but also extends these advanced services to our clients, promising a significant boost in digital engagement and market reach.
MaryJ Pharmaceuticals, Inc. is a wholly owned subsidiary whose primary service is a full-service mobile provider in the Medicinal Marijuana & HEMP industry. This would include everything from portable extraction, packaging, HIPPA compliant RFID tracking from seed to sale, delivery services, white labeling, retail products and research & development
You can see the importance of the Vertical Organizational Structure. Totally in the right direction a perfect setup for the growth of the company.
What can we now expect with respect to Shareholders ROI in the coming weeks and months?
We will be getting news on updates with the manufacturing process and let's hope we get a good bill of health. A passing grade to move us forward. I see that if all is well, we will move into copper no later than the end of May. In other words, I expect us to see copper in the next 2 weeks without much difficulty. This is also with the upcoming quarterly expect on May 15 for the first quarter of 2024. This will give us direct and hopefully good numbers. The numbers on the recent acquisition of MaryJ won't be in this quarter, but certainly in the 3rd after the growing season. The company was halting operation because of Covid.
Folks this is in a nutshell the overlook of what is coming and expected in the next few months going into the end of the year. As I have mentioned, the share price of .01 will happen shortly and once we move into clinical trials and the positive outcome to allow us moving forward .02.05 beyond the first half of 2025 is very doable. Our trading ranges from now to end of year will be .01-.025. It is after the clinical trials where the rubber meets the road.
See you all on the trading floor tomorrow.
Have a good day.
varok
Dave Oswald
@Dave_Oswald_CEO
*Final day of electrical work 🔌⚡️💡
*Dept of Ag inspection scheduled by days end 🔎
*52 week high 📈
Tweet said inspect comes day end friday
BLEG - Good morning PROPHET -of-PROFITS......Another Excellent Post of yours!........🔥
BLEG - Quote: "Old management insiders that had d's were converting but they're long gone"- Post #58994
🍀NEW MANAGEMENT NEW VENTURE!🍀......The Best is Yet To Come!.....
Imo dealing with the Florida Department of Agriculture works like this.
Call them to ask for an inspection. The week after the department calls back with the day the inspector will arrive. The inspector calls the company to set the actual time.
Bleg asked for the appointment.
Friday they gave bleg the day for the inspection this week coming.
Is it early, mid or late week? Don't know.
Bleg gets approval the kava contract that has been waiting starts and we get all kinds of news concerning it. Just imo and I didn't get this from the ceo. Read his tweets because that is where some of what is above came from. Also anyone can call the Florida agricultural department and ask like I did.
Let's get it on!
No they were to get the inspection scheduled last week. It wasn’t done this past week depending on how busy they are it could be in a few days or maybe up to 2 weeks? I’m assuming shorter than the 2 weeks guess. Inspectors know businesses want to start running when finally ready to go so they didn’t make them wait too long
Oh, was that inspection not on this past Friday?? Maybe I mis-heard or mis-read.
Just hoping since inspection was done on Friday so Approval can come as early as Monday.
Latest forecast >> Copper to Silver to Dollar to Ritirement, all in 2024.....like it or not. 😂
My day is done see yall Monday off to Matagorda beach tomorrow.
Old management insiders that had d's were converting but they're long gone. The ceo is a good guy and is imo doing it right. I'd reach out per Twitter or phone. Fyi the Inspection is this week so I don't know how busy he is to chat.
The white label kava and possibly some other contracts are going to be serious money makers. It is all about to happen. Imo read his tweets
Looking at the chart over 1 year, what was going on, dilution, bad earnings, both? Thinking about starting a position, just trying to to understand then and now better.
TEAM BLEG- I hope everyone is having a great weekend. Relax and enjoy it. We have a very busy week ahead of us. BLEG Super Sonic Jet is ready for the Blue Skies. First stop is Penny land. We will be there temporarily for a few days and then we will head out to DEEP SILVER LAND. BLEG IS SUPER GOLDEN!
Where did you find that information?
Inspection approval by monday...huge!
Good information thank
Gave you a member mark
As far as the inspection that needs to be done is on trim out if something was hooked up wrong it'll fail. That is a one-in
a million chance that happens from past experience
So on a visual inspection, I see nothing stopping this freight train
My view is to keep working on it folks....come on everybody!!!
Everything looks like it is in place and ready to run.
Go baby go
Followers
|
477
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
59037
|
Created
|
12/10/09
|
Type
|
Free
|
Moderators DTGoody Topgun21 ChannelTrader PROPHET-of-PROFITS crazy horse 0 |
CEO
David (Dave) Oswald, a dedicated professional with a passion for sustainability and a strong academic background in scientific disciplines. With an Associates of Sciences in Business Administration and a Bachelor of Sciences in Environmental Science and Micro and Molecular Biology, Dave has developed a diverse skill set. His experience encompasses laboratory work in genetics, biology, chemistry, and engineering. Through partnerships with non-profits, universities, and government departments, Dave has demonstrated a commitment to implementing sustainable practices that enhance efficiency and reduce costs. With his scientific expertise and dedication to the environment, Dave is a valuable asset in driving positive change and promoting a greener future.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |